glp-1 news september 26 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 use reaches record high
Description
Pharmacological interventions, particularly Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs), including Liraglutide and Semaglutide have emerged as a significant treatment option
They are often used in combination with a Metformin drug
Users also get access to virtual one-on-one health coaching, support groups, food and exercise trackers, and more to support their weight loss journey
a , Chemical synthesis of GLP-1MK-801 conjugates with different cysteine homologues
